JP2005507888A5 - - Google Patents

Download PDF

Info

Publication number
JP2005507888A5
JP2005507888A5 JP2003530240A JP2003530240A JP2005507888A5 JP 2005507888 A5 JP2005507888 A5 JP 2005507888A5 JP 2003530240 A JP2003530240 A JP 2003530240A JP 2003530240 A JP2003530240 A JP 2003530240A JP 2005507888 A5 JP2005507888 A5 JP 2005507888A5
Authority
JP
Japan
Prior art keywords
type
botulinum toxin
general body
body odor
cosmetic means
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003530240A
Other languages
English (en)
Japanese (ja)
Other versions
JP4966478B2 (ja
JP2005507888A (ja
Filing date
Publication date
Priority claimed from DE10146647A external-priority patent/DE10146647A1/de
Application filed filed Critical
Publication of JP2005507888A publication Critical patent/JP2005507888A/ja
Publication of JP2005507888A5 publication Critical patent/JP2005507888A5/ja
Application granted granted Critical
Publication of JP4966478B2 publication Critical patent/JP4966478B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003530240A 2001-09-21 2002-09-23 臭汗症の予防および治療のための薬剤 Expired - Lifetime JP4966478B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10146647A DE10146647A1 (de) 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis
DE10146647.1 2001-09-21
PCT/DE2002/003561 WO2003026602A2 (de) 2001-09-21 2002-09-23 Arzneimittel zur prophylaxe und therapie von bromhidrosis

Publications (3)

Publication Number Publication Date
JP2005507888A JP2005507888A (ja) 2005-03-24
JP2005507888A5 true JP2005507888A5 (https=) 2006-01-05
JP4966478B2 JP4966478B2 (ja) 2012-07-04

Family

ID=7699852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003530240A Expired - Lifetime JP4966478B2 (ja) 2001-09-21 2002-09-23 臭汗症の予防および治療のための薬剤

Country Status (16)

Country Link
US (1) US20050036966A1 (https=)
EP (2) EP2987483B1 (https=)
JP (1) JP4966478B2 (https=)
KR (1) KR100796243B1 (https=)
CN (1) CN1289061C (https=)
AU (1) AU2002349268B2 (https=)
CA (1) CA2461117C (https=)
DE (1) DE10146647A1 (https=)
EA (2) EA008146B1 (https=)
HU (1) HU230398B1 (https=)
IL (2) IL160875A0 (https=)
MX (1) MXPA04002614A (https=)
PL (1) PL209639B1 (https=)
UA (1) UA78718C2 (https=)
WO (1) WO2003026602A2 (https=)
ZA (1) ZA200402123B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113349A1 (en) 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
US7288259B2 (en) 2002-08-19 2007-10-30 Ira Sanders Treatment of holocrine gland dysfunction with clostridia neurotoxins
AU2004216901B2 (en) * 2003-03-06 2009-11-12 Botulinum Toxin Research Associates, Inc. Treatment of chronic chalazion and hordeolum with botulinum toxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
SG160357A1 (en) * 2005-03-03 2010-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
MX379265B (es) * 2008-06-26 2025-03-11 Anterios Inc Aplicacion dérmica de toxina botulínica en nanoemulsiones para usarse en el tratamiento de trastornos de la piel.
US8454975B1 (en) * 2010-01-11 2013-06-04 Elizabeth VanderVeer Method for enhancing skin appearance
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
EP3843777A4 (en) 2018-08-28 2022-05-04 Ira Sanders THERAPEUTICS FOR THE SKIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852981A1 (de) * 1998-11-17 2000-05-18 Martin Schmidt Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen
US20020086036A1 (en) * 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
US20030113349A1 (en) * 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods

Similar Documents

Publication Publication Date Title
NO20061325L (no) Kombinasjon av legemidler for behandling av neoplasmer
DE60042598D1 (de) Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist.
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
JP2007514749A5 (https=)
JP2005524663A5 (https=)
EP1558220A4 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
NO20014842L (no) Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
NO20053855L (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
JP2006514116A5 (https=)
JP2005507888A5 (https=)
WO2005011572A3 (en) Combination of drugs for the treatment of neoplasms
JO2178B1 (en) Treatment of emphysema using rar selective retinoid antagonists
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
ATE309817T1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
CA2461117A1 (en) Botulinus toxin for treatment of body odour
BRPI0407140A (pt) Droga terapêutica para vìrus
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
WO2006131651A3 (fr) Composition a base d'une avermectine et d’ηydrocortisone notamment pour le traitement de la rosacée